Alerts will be sent to your verified email
Verify Email
AAREYDRUGS
|
Aarey Drugs & Pharma
|
IndoAmerican Advance
|
Coral Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.07 % | -12.16 % | 6.99 % |
|
5yr average Equity Multiplier
|
2.28 | 1.07 | 1.2 |
|
5yr Average Asset Turnover Ratio
|
1.56 | 0.15 | 0.47 |
|
5yr Avg Net Profit Margin
|
1.44 % | -36.65 % | 12.64 % |
|
Price to Book
|
1.31 | n/a | 0.84 |
|
P/E
|
43.63 | n/a | 9.42 |
|
5yr Avg Cash Conversion Cycle
|
77.34 Days | 0.0 | 26.14 Days |
|
Inventory Days
|
20.31 Days | 0.0 | 79.65 Days |
|
Days Receivable
|
172.65 Days | 0.0 | 112.59 Days |
|
Days Payable
|
98.9 Days | 167.71 Days | 147.17 Days |
|
5yr Average Interest Coverage Ratio
|
4.14 | -55.68 | 114.88 |
|
5yr Avg ROCE
|
8.93 % | -12.15 % | 8.79 % |
|
5yr Avg Operating Profit Margin
|
1.54 % | -72.03 % | 11.85 % |
|
5 yr average Debt to Equity
|
0.21 | 0.0 | 0.03 |
|
5yr CAGR Net Profit
|
-4.17 % | n/a | 17.24 % |
|
5yr Average Return on Assets
|
2.26 % | -11.02 % | 5.83 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.8 % | 0.97 % | 71.51 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-5.23 % | -17.4 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Aarey Drugs & Pharma
|
IndoAmerican Advance
|
Coral Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|